Skin Rash – Friday Pop Quiz 6/23/2023
Which of the following treatments for the shown rash with 15% body surface area (BSA) involvement is least likely to be associated with an infection?
A. Methotrexate
B. Cyclosporine
C. Adalimumab
D. Infliximab
E. Acitretin
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…
Which of the following treatments for the shown rash with 15% body surface area (BSA) involvement is least likely to be associated with an infection?
A. Methotrexate
B. Cyclosporine
C. Adalimumab
D. Infliximab
E. Acitretin
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. April Armstrong (Professor of Dermatology and Associate Dean for Clinical Research at the Keck School of Medicine at USC) on applying the psoriasis guidelines established by the American Academy of Dermatology and the National Psor … 
Before we dive into our discussion, let’s outline the Guideline-Based Approach to Treatment Selection.
The International Psoriasis Council has divided psoriasis treatment classification into 2 groups:
Patients who are a candidate for topical therapy, or
Patients who are a candidate for systemic therapy
Candidates for systemic therapy must meet at least 1 of the following … 
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed board-certified dermatologist and dermatologic surgeon Dr. Brad Glick on his approach to patients with cutaneous signs of systemic disease.
Watch as he shares many examples of common and less common systemic diseases with dermatolog … 
During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.
CASE 1
51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA … 